Display Settings:

Format

Send to:

Choose Destination

    J Acquir Immune Defic Syndr. 2007 May 1;45(1):1-3.

    Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population.

    Zucman D, Truchis P, Majerholc C, Stegman S, Caillat-Zucman S.

    Réseau Ville-Hopital Val de Seine, Hopital Foch, Suresnes, France.

    The association of human leukocyte antigen-B*5701 with abacavir hypersensitivity varies depending on ethnic origin. We confirmed the high specificity of B*5701 in the ethnically mixed French population and used a rapid and inexpensive polymerase chain reaction strategy to evaluate the predictiveness of B*5701 screening. The incidence of hypersensitivity decreased from 12% before screening to 0% after screening, and the rate of unwarranted interruptions of abacavir therapy decreased from 10.2% to 0.73%. We therefore recommend the implementation of this cost-effective screen before treatment with abacavir.

    PMID: 17356469 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information